Magic mushroom compound meets mindfulness in new PTSD trial

NCT ID NCT07104916

First seen Mar 05, 2026 · Last updated Jun 12, 2026 · Updated 18 times

Summary

This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) combined with mindfulness-based therapy can help ease PTSD symptoms. Thirty adults with PTSD will receive the drug along with either standard support or extra mindfulness training. Researchers will use brain scans and other tests to see how the treatment affects brain activity and symptom relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Ohio State University Medical Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.